{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:00:05Z","timestamp":1787241605843,"version":"build-2736575974"},"reference-count":56,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the reproductive outcomes of patients bearing BRCA-1 and BRCA-2 mutations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective observational cohort study, we assessed data from BRCA-1 and BRCA-2 carriers, analyzing demographics, oncological history, and reproductive outcomes. Statistical analysis compared BRCA-1 and BRCA-2 carriers. A thorough review of the literature was carried out.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifty-eight patients were included. BRCA-1 and BRCA-2 mutations were equally distributed. Eighty-nine pregnancies occurred in our series, hesitated in 73 live births and 19 miscarriages. Mean age at first and last pregnancy was 27.8 \u00b1 4.8 and 31.6 \u00b1 4.8 years old. Thirty-nine patients have had at least one live birth (67.2%). Mean number of live births was 1.9 \u00b1 0.6. Live birth rate (LBR) was 81.1% and miscarriage rate was 32.8%. Spontaneous fertility was unaltered, as evidenced by high LBR. Subgroup analysis revealed no significant differences between BRCA-1 and BRCA-2 carriers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results shows that spontaneous reproductive outcomes in BRCA-mutated patients are reassuring. Despite evidence indicating a decrease in ovarian reserve among BRCA patients, this factor seems to not impact spontaneous fertility negatively. Further research is needed, and individuals with BRCA mutations should consider early family planning and fertility preservation in case of partner absence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/med-2024-9999","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T14:36:31Z","timestamp":1724164591000},"source":"Crossref","is-referenced-by-count":8,"title":["Reproductive outcomes in women with BRCA 1\/2 germline mutations: A retrospective observational study and literature review"],"prefix":"10.1515","volume":"19","author":[{"given":"Miriam","family":"Dellino","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari \u201cAldo Moro\u201d , 70124 Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"D\u2019Amato","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari \u201cAldo Moro\u201d , 70124 Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Battista","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari \u201cAldo Moro\u201d , 70124 Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Cormio","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari \u201cAldo Moro\u201d , 70124 Bari , Italy"},{"name":"Gynecologic Oncology Unit, IRCCS Istituto Tumori \u201cGiovanni Paolo II\u201d , 70124 Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Vimercati","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari \u201cAldo Moro\u201d , 70124 Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Loizzi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari \u201cAldo Moro\u201d , 70124 Bari , Italy"},{"name":"Gynecologic Oncology Unit, IRCCS Istituto Tumori \u201cGiovanni Paolo II\u201d , 70124 Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Simone","family":"Lagan\u00e0","sequence":"additional","affiliation":[{"name":"Unit of Obstetrics and Gynecology, \u201cPaolo Giaccone\u201d Hospital, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo , 90127 Palermo , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca Raffaello","family":"Damiani","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari \u201cAldo Moro\u201d , 70124 Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Favilli","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Perugia , 06132 Perugia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Gerli","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Perugia , 06132 Perugia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"La Forgia","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Istituto Tumori Giovanni Paolo II, I.R.C.C.S , 70124 Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Daniele","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Istituto Tumori Giovanni Paolo II, I.R.C.C.S , 70124 Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Agrifoglio","sequence":"additional","affiliation":[{"name":"Unit of Obstetrics and Gynecology, \u201cPaolo Giaccone\u201d Hospital, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo , 90127 Palermo , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Cicinelli","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari \u201cAldo Moro\u201d , 70124 Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amerigo","family":"Vitagliano","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari \u201cAldo Moro\u201d , 70124 Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Etrusco","sequence":"additional","affiliation":[{"name":"Unit of Obstetrics and Gynecology, \u201cPaolo Giaccone\u201d Hospital, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo , 90127 Palermo , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"key":"2024082018362670850_j_med-2024-9999_ref_001","doi-asserted-by":"crossref","unstructured":"Evans O, Gaba F, Manchanda R. Population-based genetic testing for women\u2019s cancer prevention. Best Pract Res Clin Obstet Gynaecol. 2020 May;65:139\u201353.","DOI":"10.1016\/j.bpobgyn.2020.02.007"},{"key":"2024082018362670850_j_med-2024-9999_ref_002","doi-asserted-by":"crossref","unstructured":"Yousif HMA, Mohammed RAA. Alteration of BRCA-1 tumor suppressor gene expression in serous and mucinous ovarian neoplasms in the benign-borderline-malignant pathway. Curr Probl Cancer. 2019 Aug;43(4):377\u201385.","DOI":"10.1016\/j.currproblcancer.2018.10.003"},{"key":"2024082018362670850_j_med-2024-9999_ref_003","doi-asserted-by":"crossref","unstructured":"Pecorino B, Lagan\u00e0 AS, Mereu L, Ferrara M, Carrara G, Etrusco A, et al. Evaluation of borderline ovarian tumor recurrence rate after surgery with or without fertility-sparing approach: results of a retrospective analysis. Healthcare (Basel). 2023 Jul;11(13):1922.","DOI":"10.3390\/healthcare11131922"},{"key":"2024082018362670850_j_med-2024-9999_ref_004","doi-asserted-by":"crossref","unstructured":"Matanes E, Volodarsky-Perel A, Eisenberg N, Rottenstreich M, Yasmeen A, Mitric C, et al. Endometrial cancer in germline BRCA mutation carriers: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2021 May;28(5):947\u201356.","DOI":"10.1016\/j.jmig.2020.11.023"},{"key":"2024082018362670850_j_med-2024-9999_ref_005","doi-asserted-by":"crossref","unstructured":"Paluch-Shimon S, Cardoso F, Sessa C, Balmana J, Cardoso MJ, Gilbert F, et al. Prevention and screening in BRCA mutation carriers and other breast\/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening. Ann Oncol. 2016 Sep;27(suppl 5):v103\u201310.","DOI":"10.1093\/annonc\/mdw327"},{"key":"2024082018362670850_j_med-2024-9999_ref_006","doi-asserted-by":"crossref","unstructured":"O\u2019Donovan PJ, Livingston DM. BRCA1 and BRCA2: breast\/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair. Carcinogenesis. 2010 Jun;31(6):961\u20137.","DOI":"10.1093\/carcin\/bgq069"},{"key":"2024082018362670850_j_med-2024-9999_ref_007","doi-asserted-by":"crossref","unstructured":"Honrado E, Ben\u00edtez J, Palacios J. The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications. Mod Pathol. 2005 Oct;18(10):1305\u201320.","DOI":"10.1038\/modpathol.3800453"},{"key":"2024082018362670850_j_med-2024-9999_ref_008","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017 Jun;317(23):2402\u201316."},{"key":"2024082018362670850_j_med-2024-9999_ref_009","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun;474(7353):609\u201315.","DOI":"10.1038\/nature10166"},{"key":"2024082018362670850_j_med-2024-9999_ref_010","doi-asserted-by":"crossref","unstructured":"Turner N, Tutt A, Ashworth A. Hallmarks of \u2018BRCAness\u2019 in sporadic cancers. Nat Rev Cancer. 2004 Oct;4(10):814\u20139.","DOI":"10.1038\/nrc1457"},{"key":"2024082018362670850_j_med-2024-9999_ref_011","doi-asserted-by":"crossref","unstructured":"Moschetta M, George A, Kaye SB, Banerjee S. BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer. Ann Oncol. 2016 Aug;27(8):1449\u201355.","DOI":"10.1093\/annonc\/mdw142"},{"key":"2024082018362670850_j_med-2024-9999_ref_012","doi-asserted-by":"crossref","unstructured":"John EM, Miron A, Gong G, Phipps AI, Felberg A, Li FP, et al. Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial\/ethnic groups. JAMA. 2007 Dec;298(24):2869\u201376.","DOI":"10.1001\/jama.298.24.2869"},{"key":"2024082018362670850_j_med-2024-9999_ref_013","doi-asserted-by":"crossref","unstructured":"Malone KE, Daling JR, Doody DR, Hsu L, Bernstein L, Coates RJ, et al. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res. 2006 Aug;66(16):8297\u2013308.","DOI":"10.1158\/0008-5472.CAN-06-0503"},{"key":"2024082018362670850_j_med-2024-9999_ref_014","doi-asserted-by":"crossref","unstructured":"Loboda AP, Adonin LS, Zvereva SD, Guschin DY, Korneenko TV, Telegina AV, et al. BRCA mutations \u2013 the Achilles heel of breast, ovarian and other epithelial cancers. Int J Mol Sci. 2023 Mar;24(5):4982.","DOI":"10.3390\/ijms24054982"},{"key":"2024082018362670850_j_med-2024-9999_ref_015","doi-asserted-by":"crossref","unstructured":"Winter C, Nilsson MP, Olsson E, George AM, Chen Y, Kvist A, et al. Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic. Ann Oncol. 2016 Aug;27(8):1532\u20138.","DOI":"10.1093\/annonc\/mdw209"},{"key":"2024082018362670850_j_med-2024-9999_ref_016","doi-asserted-by":"crossref","unstructured":"Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet. 2001 Mar;68(3):700\u201310.","DOI":"10.1086\/318787"},{"key":"2024082018362670850_j_med-2024-9999_ref_017","unstructured":"Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, et al. Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021 Jan;19(1):77\u2013102."},{"key":"2024082018362670850_j_med-2024-9999_ref_018","doi-asserted-by":"crossref","unstructured":"Sekine M, Enomoto T, Arai M, Den H, Nomura H, Ikeuchi T, et al. Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy. J Gynecol Oncol. 2022 Mar;33(4):e46.","DOI":"10.3802\/jgo.2022.33.e46"},{"key":"2024082018362670850_j_med-2024-9999_ref_019","doi-asserted-by":"crossref","unstructured":"Eleje GU, Eke AC, Ezebialu IU, Ikechebelu JI, Ugwu EO, Okonkwo OO. Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations. Cochrane Database Syst Rev. 2018 Aug;8(8):CD012464.","DOI":"10.1002\/14651858.CD012464.pub2"},{"key":"2024082018362670850_j_med-2024-9999_ref_020","doi-asserted-by":"crossref","unstructured":"Marchetti C, De Felice F, Palaia I, Perniola G, Musella A, Musio D, et al. Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers. BMC Womens Health. 2014 Dec;14:150.","DOI":"10.1186\/s12905-014-0150-5"},{"key":"2024082018362670850_j_med-2024-9999_ref_021","doi-asserted-by":"crossref","unstructured":"Titus S, Li F, Stobezki R, Akula K, Unsal E, Jeong K, et al. Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans. Sci Transl Med. 2013 Feb;5(172):172ra21.","DOI":"10.1126\/scitranslmed.3004925"},{"key":"2024082018362670850_j_med-2024-9999_ref_022","doi-asserted-by":"crossref","unstructured":"Turan V, Oktay K. BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging. Hum Reprod Update. 2020 Jan;26(1):43\u201357.","DOI":"10.1093\/humupd\/dmz043"},{"key":"2024082018362670850_j_med-2024-9999_ref_023","doi-asserted-by":"crossref","unstructured":"Oktay K, Turan V, Titus S, Stobezki R, Liu L. BRCA mutations, DNA repair deficiency, and ovarian aging. Biol Reprod. 2015 Sep;93(3):67.","DOI":"10.1095\/biolreprod.115.132290"},{"key":"2024082018362670850_j_med-2024-9999_ref_024","doi-asserted-by":"crossref","unstructured":"Lambertini M, Goldrat O, Ferreira AR, Dechene J, Azim Jr HA, Desir J, et al. Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients. Ann Oncol. 2018 Jan;29(1):237\u201343.","DOI":"10.1093\/annonc\/mdx639"},{"key":"2024082018362670850_j_med-2024-9999_ref_025","doi-asserted-by":"crossref","unstructured":"Porcu E, Cillo GM, Cipriani L, Sacilotto F, Notarangelo L, Damiano G, et al. Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer. J Assist Reprod Genet. 2020 Mar;37(3):709\u201315.","DOI":"10.1007\/s10815-019-01658-9"},{"key":"2024082018362670850_j_med-2024-9999_ref_026","doi-asserted-by":"crossref","unstructured":"Buonomo B, Massarotti C, Dellino M, Anserini P, Ferrari A, Campanella M, et al. Reproductive issues in carriers of germline pathogenic variants in the BRCA1\/2 genes: an expert meeting. BMC Med. 2021 Sep;19(1):205.","DOI":"10.1186\/s12916-021-02081-7"},{"key":"2024082018362670850_j_med-2024-9999_ref_027","doi-asserted-by":"crossref","unstructured":"Wang ET, Pisarska MD, Bresee C, Chen YDI, Lester J, Afshar Y, et al. BRCA1 germline mutations may be associated with reduced ovarian reserve. Fertil Steril. 2014 Dec;102(6):1723\u20138.","DOI":"10.1016\/j.fertnstert.2014.08.014"},{"key":"2024082018362670850_j_med-2024-9999_ref_028","doi-asserted-by":"crossref","unstructured":"Giordano S, Garrett-Mayer E, Mittal N, Smith K, Shulman L, Passaglia C, et al. Association of BRCA1 mutations with impaired ovarian reserve: connection between infertility and breast\/ovarian cancer risk. J Adolesc Young Adult Oncol. 2016 Dec;5(4):337\u201343.","DOI":"10.1089\/jayao.2016.0009"},{"key":"2024082018362670850_j_med-2024-9999_ref_029","unstructured":"Statistics | Eurostat [Internet]. [cited 2023 Aug 21]. Available from: https:\/\/ec.europa.eu\/eurostat\/databrowser\/view\/demo_find\/default\/table?lang=en."},{"key":"2024082018362670850_j_med-2024-9999_ref_030","doi-asserted-by":"crossref","unstructured":"Kufel-Grabowska J, Podolak A, Maliszewski D, Bartoszkiewicz M, Ramlau R, Lukaszuk K. Fertility counseling in BRCA1\/2-mutated women with breast cancer and healthy individuals. J Clin Med. 2022 Jan;11(14):3996.","DOI":"10.3390\/jcm11143996"},{"key":"2024082018362670850_j_med-2024-9999_ref_031","unstructured":"Istituto Nazionale di Statistica [ISTAT]; 2021. Report Natalit\u00e0 2021. https:\/\/www.istat.it\/it\/files\/2022\/12\/report-natalita-2021.pdf."},{"key":"2024082018362670850_j_med-2024-9999_ref_032","doi-asserted-by":"crossref","unstructured":"Kwiatkowski F, Arbre M, Bidet Y, Laquet C, Uhrhammer N, Bignon YJ. BRCA mutations increase fertility in families at hereditary breast\/ovarian cancer risk. Plos One. 2015 Jun;10(6):e0127363.","DOI":"10.1371\/journal.pone.0127363"},{"key":"2024082018362670850_j_med-2024-9999_ref_033","doi-asserted-by":"crossref","unstructured":"Zhang X, Niu J, Che T, Zhu Y, Zhang H, Qu J. Fertility preservation in BRCA mutation carriers \u2013 efficacy and safety issues: a review. Reprod Biol Endocrinol. 2020 Feb;18(1):11.","DOI":"10.1186\/s12958-019-0561-0"},{"key":"2024082018362670850_j_med-2024-9999_ref_034","doi-asserted-by":"crossref","unstructured":"Etrusco A, Lagan\u00e0 AS, Chiantera V, Buzzaccarini G, Unfer V. Myo-inositol in assisted reproductive technology from bench to bedside. Trends Endocrinol Metab. 2024 Jan;35(1):74\u201383.","DOI":"10.1016\/j.tem.2023.09.005"},{"key":"2024082018362670850_j_med-2024-9999_ref_035","doi-asserted-by":"crossref","unstructured":"Dragotto J, Buzzaccarini G, Etrusco A, Lagan\u00e0 AS, Venezia R, Terzic S, et al. Effects of low luteinizing hormone serum levels on oocyte retrieval, fertilization rate, and embryo quality during controlled ovarian stimulation: results from a prospective cohort analysis. Gynecol Obstet Invest. 2024;89(1):50\u20138.","DOI":"10.1159\/000534860"},{"key":"2024082018362670850_j_med-2024-9999_ref_036","doi-asserted-by":"crossref","unstructured":"Gullo G, Etrusco A, Cucinella G, Perino A, Chiantera V, Lagan\u00e0 AS, et al. Fertility-sparing approach in women affected by stage I and low-grade endometrial carcinoma: an updated overview. Int J Mol Sci. 2021 Oct;22(21):11825.","DOI":"10.3390\/ijms222111825"},{"key":"2024082018362670850_j_med-2024-9999_ref_037","doi-asserted-by":"crossref","unstructured":"Etrusco A, Lagan\u00e0 AS, Chiantera V, Miku\u0161 M, Arsalan HM, d\u2019Amati A, et al. Reproductive and oncologic outcomes in young women with stage IA and grade 2 endometrial carcinoma undergoing fertility-sparing treatment: a systematic review. Biomolecules. 2024 Mar;14(3):306.","DOI":"10.3390\/biom14030306"},{"key":"2024082018362670850_j_med-2024-9999_ref_038","doi-asserted-by":"crossref","unstructured":"D\u2019Amato A, Riemma G, Agrifoglio V, Chiantera V, Lagan\u00e0 AS, Miku\u0161 M, et al. Reproductive outcomes in young women with early-stage cervical cancer greater than 2 cm undergoing fertility-sparing treatment: a systematic review. Medicina (Kaunas). 2024 Apr;60(4):608.","DOI":"10.3390\/medicina60040608"},{"key":"2024082018362670850_j_med-2024-9999_ref_039","doi-asserted-by":"crossref","unstructured":"Etrusco A, Buzzaccarini G, Lagan\u00e0 AS, Chiantera V, Vitale SG, Angioni S, et al. Use of diode laser in hysteroscopy for the management of intrauterine pathology: a systematic review. Diagnostics (Basel). 2024 Feb 2;14(3):327.","DOI":"10.3390\/diagnostics14030327"},{"key":"2024082018362670850_j_med-2024-9999_ref_040","doi-asserted-by":"crossref","unstructured":"Etrusco A, Lagan\u00e0 AS, Chiantera V, Gerli S, Carugno J, Sorrentino F, et al. Efficacy, safety, and feasibility of the treatment of intrauterine pathologies with the mini-resectoscope: a systematic review. Int J Gynaecol Obstet. 2024;166(2):527\u201337.","DOI":"10.1002\/ijgo.15393"},{"key":"2024082018362670850_j_med-2024-9999_ref_041","unstructured":"Gullo G, Etrusco A, Cucinella G, Basile G, Fabio M, Perino A, et al. Ovarian tissue cryopreservation and transplantation in menopause: new perspective of therapy in postmenopausal women and the importance of ethical and legal frameworks. Eur Rev Med Pharmacol Sci. 2022 Dec;26(24):9107\u201316."},{"key":"2024082018362670850_j_med-2024-9999_ref_042","doi-asserted-by":"crossref","unstructured":"Streuli I, de Mouzon J, Paccolat C, Chapron C, Petignat P, Irion OP, et al. AMH concentration is not related to effective time to pregnancy in women who conceive naturally. Reprod Biomed Online. 2014 Feb;28(2):216\u201324.","DOI":"10.1016\/j.rbmo.2013.10.007"},{"key":"2024082018362670850_j_med-2024-9999_ref_043","doi-asserted-by":"crossref","unstructured":"Ben-Aharon I, Levi M, Margel D, Yerushalmi R, Rizel S, Perry S, et al. Premature ovarian aging in BRCA carriers: a prototype of systemic precocious aging? Oncotarget. 2018 Mar 23;9(22):15931\u201341.","DOI":"10.18632\/oncotarget.24638"},{"key":"2024082018362670850_j_med-2024-9999_ref_044","doi-asserted-by":"crossref","unstructured":"van Tilborg TC, Derks-Smeets IAP, Bos AME, Oosterwijk JC, van Golde RJ, de Die-Smulders CE, et al. Serum AMH levels in healthy women from BRCA1\/2 mutated families: are they reduced? Hum Reprod. 2016 Nov;31(11):2651\u20139.","DOI":"10.1093\/humrep\/dew242"},{"key":"2024082018362670850_j_med-2024-9999_ref_045","doi-asserted-by":"crossref","unstructured":"Michaelson-Cohen R, Mor P, Srebnik N, Beller U, Levy-Lahad E, Eldar-Geva T. BRCA mutation carriers do not have compromised ovarian reserve. Int J Gynecol Cancer. 2014 Feb;24(2):233\u20137.","DOI":"10.1097\/IGC.0000000000000058"},{"key":"2024082018362670850_j_med-2024-9999_ref_046","doi-asserted-by":"crossref","unstructured":"Finch A, Valentini A, Greenblatt E, Lynch HT, Ghadirian P, Armel S, et al. Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation. Fertil Steril. 2013 May;99(6):1724\u20138.","DOI":"10.1016\/j.fertnstert.2013.01.109"},{"key":"2024082018362670850_j_med-2024-9999_ref_047","doi-asserted-by":"crossref","unstructured":"Tomao F, Di Pinto A, Sassu CM, Bardhi E, Di Donato V, Muzii L, et al. Fertility preservation in ovarian tumours. Ecancermedicalscience. 2018;12:885.","DOI":"10.3332\/ecancer.2018.885"},{"key":"2024082018362670850_j_med-2024-9999_ref_048","doi-asserted-by":"crossref","unstructured":"Oktay K, Kim JY, Barad D, Babayev SN. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast\/ovarian cancer risks. JCO. 2010 Jan;28(2):240\u20134.","DOI":"10.1200\/JCO.2009.24.2057"},{"key":"2024082018362670850_j_med-2024-9999_ref_049","doi-asserted-by":"crossref","unstructured":"Son KA, Lee DY, Choi D. Association of BRCA mutations and anti-m\u00fcllerian hormone level in young breast cancer patients. Front Endocrinol. 2019;10. [cited 2023 Jul 27]. https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2019.00235.","DOI":"10.3389\/fendo.2019.00235"},{"key":"2024082018362670850_j_med-2024-9999_ref_050","doi-asserted-by":"crossref","unstructured":"Daum H, Peretz T, Laufer N. BRCA mutations and reproduction. Fertil Steril. 2018 Jan;109(1):33\u20138.","DOI":"10.1016\/j.fertnstert.2017.12.004"},{"key":"2024082018362670850_j_med-2024-9999_ref_051","unstructured":"Terry MB, Liao Y, Kast K, Antoniou AC, McDonald JA, Mooij TM, et al. The influence of number and timing of pregnancies on breast cancer risk for women with BRCA1 or BRCA2 mutations. JNCI Cancer Spectr. 2018 Oct;2(4):pky078."},{"key":"2024082018362670850_j_med-2024-9999_ref_052","doi-asserted-by":"crossref","unstructured":"Albrektsen G, Heuch I, Thoresen S, Kv\u00e5le G. Clinical stage of breast cancer by parity, age at birth, and time since birth: a progressive effect of pregnancy hormones? Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):65\u20139.","DOI":"10.1158\/1055-9965.EPI-05-0634"},{"key":"2024082018362670850_j_med-2024-9999_ref_053","doi-asserted-by":"crossref","unstructured":"Kotsopoulos J, Lubinski J, Salmena L, Lynch HT, Kim-Sing C, Foulkes WD, et al. Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2012;14(2):R42.","DOI":"10.1186\/bcr3138"},{"key":"2024082018362670850_j_med-2024-9999_ref_054","doi-asserted-by":"crossref","unstructured":"Lambertini M, Blondeaux E, Bruzzone M, Perachino M, Anderson RA, de Azambuja E, et al. Pregnancy after breast cancer: a systematic review and meta-analysis. JCO. 2021 Oct;39(29):3293\u2013305.","DOI":"10.1200\/JCO.21.00535"},{"key":"2024082018362670850_j_med-2024-9999_ref_055","doi-asserted-by":"crossref","unstructured":"Azim HA, Ameye L, Paesmans M, Lambertini M. Reply to S. A. Narod et al. JCO. 2020 Dec;38(36):4352\u20134.","DOI":"10.1200\/JCO.20.02850"},{"key":"2024082018362670850_j_med-2024-9999_ref_056","doi-asserted-by":"crossref","unstructured":"Lambertini M, Ameye L, Hamy AS, Zingarello A, Poorvu PD, Carrasco E, et al. Pregnancy after breast cancer in patients with germline BRCA mutations. JCO. 2020 Sep;38(26):3012\u201323.","DOI":"10.1200\/JCO.19.02399"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2024-9999\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2024-9999\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T14:36:45Z","timestamp":1724164605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2024-9999\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,8,20]]},"published-print":{"date-parts":[[2024,8,20]]}},"alternative-id":["10.1515\/med-2024-9999"],"URL":"https:\/\/doi.org\/10.1515\/med-2024-9999","relation":{},"ISSN":["2391-5463"],"issn-type":[{"value":"2391-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,1]]},"article-number":"20249999"}}